Paper15548366
Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.
Yao R and 5 others. Neoplasia, 2004. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine. Papers, record 15548366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15548366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butylhydroxybutylnitrosamine | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Animals | |
| Down-Regulation | |
| GTP-Binding Protein alpha Subunits, G12-G13 | |
| Gene Expression Profiling | |
| Mice | |
| Mice, Inbred Strains | |
| Oligonucleotide Array Sequence Analysis | |
| Signal Transduction | |
| Transforming Growth Factor beta | |
| Up-Regulation |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8872613 | Retinoblastoma protein family in cell cycle and cancer: a review. | J Cell Biochem | 1996 | https://conductscience.org/library/papers/8872613 | PubMed |
| 2 | 11738596 | Dbl family guanine nucleotide exchange factors. | Trends Biochem Sci | 2001 | https://conductscience.org/library/papers/11738596 | PubMed |
| 3 | 12438227 | RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. | Cancer Res | 2002 | https://conductscience.org/library/papers/12438227 | PubMed |
| 4 | 12480336 | Rho GTPase-activating proteins in cell regulation. | Trends Cell Biol | 2003 | https://conductscience.org/library/papers/12480336 | PubMed |
| 5 | 12490193 | Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. | Exp Cell Res | 2003 | https://conductscience.org/library/papers/12490193 | PubMed |
| 6 | 12568441 | Cancer statistics, 2003. | CA Cancer J Clin | 2003 | https://conductscience.org/library/papers/12568441 | PubMed |
| 7 | 12635176 | RHO-GTPases and cancer. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12635176 | PubMed |
| 8 | 12827207 | Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast. | Nature | 2003 | https://conductscience.org/library/papers/12827207 | PubMed |
| 9 | 12808151 | Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12808151 | PubMed |
| 10 | 12895299 | Ras oncogene mutations in urine sediments of patients with bladder cancer. | J Biochem Mol Biol | 2003 | https://conductscience.org/library/papers/12895299 | PubMed |
| 11 | 14737103 | p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. | Oncogene | 2004 | https://conductscience.org/library/papers/14737103 | PubMed |
| 12 | 910158 | 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. | Science | 1977 | https://conductscience.org/library/papers/910158 | PubMed |
| 13 | 2247480 | Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2247480 | PubMed |
| 14 | 1868471 | Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. | Cancer Res | 1991 | https://conductscience.org/library/papers/1868471 | PubMed |
| 15 | 1427748 | Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. | Hum Pathol | 1992 | https://conductscience.org/library/papers/1427748 | PubMed |
| 16 | 8078295 | Urinary bladder cancer: mechanisms of development and progression. | Lab Invest | 1994 | https://conductscience.org/library/papers/8078295 | PubMed |
| 17 | 7877684 | Principles of CDK regulation. | Nature | 1995 | https://conductscience.org/library/papers/7877684 | PubMed |
| 18 | 7613858 | Molecular genetics of bladder cancer. | Br J Urol | 1995 | https://conductscience.org/library/papers/7613858 | PubMed |
| 19 | 7503932 | Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7503932 | PubMed |
| 20 | 8947520 | Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors. | Cancer Lett | 1996 | https://conductscience.org/library/papers/8947520 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36805539 | FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. | Commun Biol | 2023 | https://conductscience.org/library/papers/36805539 | PubMed |
| 32024545 | Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model. | J Transl Med | 2020 | https://conductscience.org/library/papers/32024545 | PubMed |
| 31779626 | The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice. | J Transl Med | 2019 | https://conductscience.org/library/papers/31779626 | PubMed |
| 30066698 | Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30066698 | PubMed |
| 29367767 | A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer. | Oncogene | 2018 | https://conductscience.org/library/papers/29367767 | PubMed |
| 28915710 | Insights from animal models of bladder cancer: recent advances, challenges, and opportunities. | Oncotarget | 2017 | https://conductscience.org/library/papers/28915710 | PubMed |
| 28588015 | Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28588015 | PubMed |
| 27378170 | Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. | Sci Rep | 2016 | https://conductscience.org/library/papers/27378170 | PubMed |
| 27376116 | Id Proteins Contribute to Tumor Development and Metastatic Colonization in a Model of Bladder Carcinogenesis. | Bladder Cancer | 2015 | https://conductscience.org/library/papers/27376116 | PubMed |
| 23730403 | Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. | Transl Oncol | 2013 | https://conductscience.org/library/papers/23730403 | PubMed |
| 22028816 | Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model. | PLoS One | 2011 | https://conductscience.org/library/papers/22028816 | PubMed |
| 20816503 | The use of animal models for cancer chemoprevention drug development. | Semin Oncol | 2010 | https://conductscience.org/library/papers/20816503 | PubMed |
| 19214530 | Experimental animal model and RNA interference: a promising association for bladder cancer research. | World J Urol | 2009 | https://conductscience.org/library/papers/19214530 | PubMed |
| 19138991 | Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. | Cancer Prev Res (Phila) | 2008 | https://conductscience.org/library/papers/19138991 | PubMed |
| 18670642 | Molecular credentialing of rodent bladder carcinogenesis models. | Neoplasia | 2008 | https://conductscience.org/library/papers/18670642 | PubMed |
| 17401461 | Gene expression profiling of chemically induced rat bladder tumors. | Neoplasia | 2007 | https://conductscience.org/library/papers/17401461 | PubMed |
| 16354585 | A review of the past, present, and future directions of neoplasia. | Neoplasia | 2005 | https://conductscience.org/library/papers/16354585 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SMAD2 | 4087 | PubTator's text mining | https://conductscience.org/library/genes/4087 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15548366
GET https://conductscience.org/api/papers/v1/15548366/references?page=2